Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.66
Delayed Data
As of Mar 30
 -0.02 / -1.19%
Today’s Change
0.97
Today|||52-Week Range
2.02
-12.17%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.68
Today’s open1.68
Day’s range1.63 - 1.70
Volume247,867
Average volume (3 months)614,537
Market cap$252.6M
Dividend yield--
Data as of 4:05pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+47.92%
Earnings growth (next 5 years)--
Revenue growth (last year)+301.01%
P/E ratioNM
Price/Sales62.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SNTASynta Pharmaceutical...+0.03+1.30%
POZNPOZEN Inc+0.01+0.13%
PPHMPeregrine Pharmaceut...-0.01-0.36%
VTAEVitae Pharmaceutical...+0.10+0.89%
Data as of 4:00pm ET, 03/30/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$4.5M
Annual profit (last year)-$35.7M
Net profit margin-787.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account